Abstract
In order to maximize the efficacy of PAE, choosing the appropriate patients is important. The first step is determining if the patient has LUTS secondary to BPH as well as ruling out etiologies that result in bladder dysfunction. This can be achieved through a thorough urologic evaluation that may also include cystoscopy and urodynamic testing. Subsequently, the feasibility of technical success should be assessed by evaluating the arterial anatomy and reviewing the patient’s history for red flags such as prior vascular surgery and evidence of renal dysfunction.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Barry MJ, Fowler FJ Jr, O’Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, et al. The American Urological association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol. 1992;148(5):1549–57.
Rosen RC, Cappelleri JC, Gendrano N 3rd. The International Index of Erectile Function (IIEF): a state-of-the-science review. Int J Impot Res. 2002;14:226–44.
Yu SCH, Cho CCM, Hung EHY, Chiu PKF, Yee CH, Ng CF. Prostate artery embolization for complete urinary outflow obstruction due to benign prostatic hypertrophy. Cardiovasc Intervent Radiol. 2017;40(1):33–40.
Patel AK, Chapple CR. Benign prostatic hyperplasia: treatment in primary care. BMJ. 2006;333:535–9.
Hatzimouratidis K. A review of the use of tadalafil in the treatment of benign prostatic hyperplasia in men with and without erectile dysfunction. Ther Adv Urol. 2014;6(4):135–47.
Wang M, Guo L, Duan F, Yuan K, Zhang G, Li K, et al. Prostatic arterial embolization for the treatment of lower urinary tract symptoms caused by benign prostatic hyperplasia: a comparative study of medium- and large-volume prostates. BJU Int. 2016;117:155–64.
Maclean D, Harris M, Drake T, Maher B, Modi S, Dyer J, et al. Factors predicting a good symptomatic outcome after prostate artery embolisation (PAE). Cardiovasc Intervent Radiol. 2018;41(8):1152–9.
Bagla S, Smirniotopoulos JB, Orlando JC, van Breda A, Vadlamudi V. Comparative analysis of prostate volume as a predictor of outcome in prostate artery embolization. J Vasc Interv Radiol. 2015;26(12):1832–8.
Kaplan SA. Identification of the patient with enlarged prostate: diagnosis and guidelines for management. Osteopath Med Prim Care. 2007;1:11.
Frydenberg M, Wijesinha S. Diagnosing prostate cancer—what GPs need to know. Aust Fam Physician. 2007;36:345–7.
Gomez C, Bhatia S, Carnevale FC, Narayanan G. Role of urodynamic studies in management of benign prostatic obstruction: a guide for interventional radiologists. J Vasc Interv Radiol. 2017;28:126–33.
Gratzke C, Bachmann A, Descazeaud A, Drake MJ, Madersbacher S, Mamoulakis C, et al. EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol. 2015;67:1099–109.
McVary KT, Roehrborn CG, Avins AL, Barry MJ, Bruskewitz RC, Donnell RF, et al. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol. 2012;185:1793–803.
Bates CP, Whiteside CG, Turner Warwick R. Synchronous urine pressure flow cystourethrography with special reference to stress and urge incontinence. Br J Urol. 1970;42:714.
Abrams P. Urodynamic techniques. In: Urodynamics. 3rd ed. London: Springer; 2006. p. 17–116.
Burnett AL, Wein AJ. Benign prostatic hyperplasia in primary care: what you need to know. J Urol. 2006;175:S19–24.
Pereira JA, Bilhim T, Duarte M, Rio Tinto H, Fernandes L, Martins Pisco J. Patient selection and counseling before prostatic arterial embolization. Tech Vasc Interv Radiol. 2012;15:270–5.
Kim JI, Dixon RG, Isaacson AI. Translgluteal prostatic artery enmbolization. J Vasc Interv Radiol. 2016;29(1):90–1.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Devulapalli, K.K., Nutting, C.W., Isaacson, A.J. (2020). Patient Selection for Prostatic Artery Embolization. In: Isaacson, A., Bagla, S., Raynor, M., Yu, H. (eds) Prostatic Artery Embolization. Springer, Cham. https://doi.org/10.1007/978-3-030-23471-3_8
Download citation
DOI: https://doi.org/10.1007/978-3-030-23471-3_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-23470-6
Online ISBN: 978-3-030-23471-3
eBook Packages: MedicineMedicine (R0)